BPH Global Ltd (USZ0.F)

0.0005 0.0000 (0.00%) 收市：08:13AM CEST

BPH Global Ltd

Block Arcade, 96 Elizabeth St.
Level 3 Office 324
Melbourne, VIC 3000
Australia
61 2 8072 1400
https://www.scu.com.sg

版塊: Healthcare
行業: Drug Manufacturers - Specialty & Generic
全職員工: 

高階主管

名稱	頭銜	支付	行使價	出生年份
Mr. Matthew Robert Leonard	MD & Executive Director	70.89k	無	無
Mr. Chow-Yee Koh	Chief Financial Officer	136.61k	無	1976
Mr. Francesco Cannavo	Part-Time Executive Director	115.83k	無	無
Mr. Justyn Peter Stedwell B.Com, B.Com.	Company Secretary	無	無	無

截止 2023年12月31日為止計算的金額，現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 EUR。

描述

BPH Global Ltd, together with its subsidiaries, engages in sourcing, producing, marketing, and selling traditional medicines in Australia, Singapore, China, and Malaysia. Its products include Caulerpa Lentillifera, a sea grape extract; Dendrobium Officinale Kimura et Migo, an orchid; Resina, a Daemonorops Draco Blume extract; and Cannabis Sativa, an industrial hemp. The company was formerly known as Stemcell United Limited and changed its name to BPH Global Ltd in June 2023. BPH Global Ltd was incorporated in 1984 and is headquartered in Melbourne, Australia.

公司管治

截至 無 止，BPH Global Ltd 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中：無；董事會：無；股東權利：無；現金賠償：無。

企業管治評分的資料提供： Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險，而 10 分表示較高的管治風險。